US federal health agencies have recommended pausing the use of Johnson & Johnson’s single-dose Covid vaccine after six recipients developed a rare disorder involving blood clots. The US Centers for Disease Control and Prevention will hold an advisory meeting on Wednesday to review the cases. The US Food and Drug Administration sought to reassure the public that the side effects “appear to be extremely rare”.
The FDA said it will be reviewing the data and the cases where the “rare and severe” blood clots were developed.
They said in a statement posted on Twitter: “#COVID19 vaccine safety is a top priority for the federal government, and we take all reports of health problems following COVID-19 vaccination very seriously.”
MORE TO FOLLOW…